The AIM index slumped at the open and failed to post any signs of recovery through Thursday’s session, finishing a little over eight points lower at 940.82
- Tekcapital up 17%
- Katoro Gold up 15%
- Notable mention ValiRx up 14%
- Integumen down 27%
- Modern Water down 20%
Tekcapital [LON:TEK] makes it back onto the agenda today with news of another distribution deal for MicroSalt, a product owned by one of its portfolio companies. Shares advanced 17%, leaving the stock at the top of the board.
Katoro Gold [LON:KAT] also fared well, adding 15% in a busy day of trade. Back in July, the company agreed a formal extension to the financing of a project in South Africa. The deadline for that to be confirmed is September 30th – some investors may be speculating that good news here is imminent.
Integumen [LON:SKIN] may have been expecting a better day, after releasing an RNS which included updates on technologies it has been developing to detect COVID. Volumes were well ahead of recent levels but it’s as if the AGM which also took place during the day was expected to deliver considerably more than it did. Shares finished 27% lower.
Modern Water [LON:MWG] was the other big casualty, off 20%. The company is set to be acquired by Integumen in an all share deal, so the move can be explained by that sell off at the soon to be parent.
Notable mention for ValiRx [LON:VAL], which added 14% during the day, continuing its stellar run. At one point mid-morning, the share price was close on having trebled in the space of a week, breaching 65p before settling back at 59.5p. That hotly anticipated update on its VAL-201 clinical trials is still due by the end of the month.